Key Metrics of Alpha Teknova
Revenue$36.7M▼ 11.4% YoYFY 2023
Operating income−$35.6M▲ 28.4% YoY
Net profit−$36.8M▲ 22.5% YoY
Shareholders' equity$90.0M
Market cap$485MTKNO · $7.86
Competitors10identified
About Alpha Teknova
Sectors
Company details
- Website
- teknova.com/en.html
- Founded
- 2021
- Listed
- Nasdaq: TKNO (since 2021)
Operational Areas of Alpha Teknova
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameAlpha Teknova Inc.
TickerTKNO
ExchangeNasdaq
CountryUnited States
SEC CIK0001850902
Listed since2021
IndustryBiotechnology: In Vitro & In Vivo Diagnostic Substances
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttps://www.teknova.com/en.html
US market & SEC filings
TKNO · Nasdaq · SEC CIK 0001850902
Last price · 07 Nov 2026
$7.86
+6.64%
Market cap$485M
P/E—On FY 2023 diluted EPS
Volume967,480
SectorHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances
Country · IPOUnited StatesListed 2021
TKNO share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeHollister
GSTIN—
Email—
Websitehttps://www.teknova.com/en.html
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Alpha Teknova
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
biotechnology
Filings
No filings on record yet.